Clinical Trials Logo

Clinical Trial Summary

Reflux symptoms index (RSI) were developed to identify a clinical index of suspicion for laryngopharyngeal reflux (LPR) in patients with ear, nose, and throat symptoms. RSI is an efficient diagnostic tool for LPR/ It is easy to use, even for those who know little about LPR. It does not require special equipment or examinations and is inexpensive. Thus, it can be considered highly efficient and cost-effective. The study will focus on translating and testing the RSI into Kazakh language and comparing its results in healthy people and people with laryngopharyngeal reflux.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05296655
Study type Observational
Source Kazakh Medical University of Continuing Education
Contact
Status Completed
Phase
Start date March 1, 2020
Completion date February 16, 2022

See also
  Status Clinical Trial Phase
Completed NCT04988347 - Spirulina Platensis for PPI Withdrawal Phase 2
Completed NCT03322553 - Endoscopic Full Thickness Plication (GERD-X) for the Treatment of PPI Dependent GERD: N/A
Recruiting NCT04884074 - Effect of Routine Anterior Crural Repair in De-Novo Gastroesophageal Reflux After Laparoscopic Sleeve Gastrectomy N/A
Completed NCT01503476 - Development of Applications of the Bravo® pH Monitoring System and Evaluation of Its Performance Phase 4
Withdrawn NCT01788085 - Development of Applications of the Bravo® pH Monitoring System and Evaluation of Its Performance (Encore) N/A
Enrolling by invitation NCT05678491 - Endoscopic Treatment of Gastroesophageal Reflux Disease N/A